摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl (4-hydroxy-2-methylquinolin-3-yl)acetate | 848132-47-8

中文名称
——
中文别名
——
英文名称
ethyl (4-hydroxy-2-methylquinolin-3-yl)acetate
英文别名
ethyl 2-(4-hydroxy-2-methylquinolin-3-yl)acetate;Ethyl (4-hydroxy-2-methylquinolin-3-yl)acetate;ethyl 2-(2-methyl-4-oxo-1H-quinolin-3-yl)acetate
ethyl (4-hydroxy-2-methylquinolin-3-yl)acetate化学式
CAS
848132-47-8
化学式
C14H15NO3
mdl
——
分子量
245.278
InChiKey
JIMWVIXDHCBJTI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    393.9±37.0 °C(Predicted)
  • 密度:
    1?+-.0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl (4-hydroxy-2-methylquinolin-3-yl)acetatesodium hydroxide氯化亚砜 作用下, 以 吡啶乙醇N,N-二甲基甲酰胺 为溶剂, 反应 7.0h, 生成 N1-[(4-hydroxy-2-methylquinolin-3-yl)acetyl]thiosemicarbazide
    参考文献:
    名称:
    New Quinoline Derivatives on the Basis of (4-Hydroxy-2-methylquinolin-3-yl)acetic Acid
    摘要:
    A procedure was developed for the synthesis of (4-hydroxy-2-methylquinolin-3-yl)acetic acid and the corresponding acyl chloride. Reactions of the latter with o-aminobenzenethiol, o-phenylenediamine, o-aminophenol, anthranilic acid, and thiosemicarbazide gave, respectively, 2-(4-hydroxy-2-methylquinolin-3ylmethyl)-1,3-benzothiazole, -benzoxazole, -benzimidazole, 2-(4-hydroxy-2-methylquinolin-3-ylmethyl)-4H3,1-benzoxazin-4-one, and 4-hydroxy-2-methyl-3-(5-sulfanyl-1H-1,2,4-triazol-3-ylmethyl)quinoline.
    DOI:
    10.1023/b:rujo.0000044555.03402.9b
  • 作为产物:
    描述:
    乙酰琥珀酸二乙酯 在 Amberlyst 15 作用下, 以 二苯醚甲苯 为溶剂, 反应 72.1h, 生成 ethyl (4-hydroxy-2-methylquinolin-3-yl)acetate
    参考文献:
    名称:
    [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
    [FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
    摘要:
    公式I的化合物:其中c、R2、R3、R4、R5、R6、R7和R8按本说明定义,可用作HIV复制的抑制剂。
    公开号:
    WO2009062289A1
点击查看最新优质反应信息

文献信息

  • [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2009062289A1
    公开(公告)日:2009-05-22
    Compounds of formula I : wherein c, R2, R3, R4, R5, R6, R7 and R8 are defined herein, are useful as inhibitors of HIV replication.
    公式I的化合物:其中c、R2、R3、R4、R5、R6、R7和R8按本说明定义,可用作HIV复制的抑制剂。
  • Synthesis of Quinolinyl-Substituted Five-Membered Heterocycles and Schiff Bases from 2-(4-Hydroxy-2-methylquinolin-3-yl)acetohydrazide
    作者:I. L. Aleksanyan、L. P. Hambardzumyan
    DOI:10.1134/s1070428020120118
    日期:2020.12
    Quinolinyl-substituted five-membered heterocyclic compounds containing 1,3,4-oxadiazole, 1,3-dioxoisoindole, 1,2,4-triazole, and 1,3,4-thiadiazole rings and Schiff bases were synthesized starting from 2-(4-hydroxy-2-methylquinolin-3-yl)acetohydrazide.
    摘要 由2-(-)开始合成包含1,3,4-恶二唑,1,3-二氧杂异吲哚,1,2,4-三唑和1,3,4-噻二唑环和席夫碱的喹啉基取代的五元杂环化合物4-羟基-2-甲基喹啉-3-基)乙酰肼。
  • WO2007/131350
    申请人:——
    公开号:——
    公开(公告)日:——
  • INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP2019825B1
    公开(公告)日:2010-09-01
  • New Quinoline Derivatives on the Basis of (4-Hydroxy-2-methylquinolin-3-yl)acetic Acid
    作者:A. A. Avetisyan、I. L. Aleksanyan、A. A. Pivazyan
    DOI:10.1023/b:rujo.0000044555.03402.9b
    日期:2004.6
    A procedure was developed for the synthesis of (4-hydroxy-2-methylquinolin-3-yl)acetic acid and the corresponding acyl chloride. Reactions of the latter with o-aminobenzenethiol, o-phenylenediamine, o-aminophenol, anthranilic acid, and thiosemicarbazide gave, respectively, 2-(4-hydroxy-2-methylquinolin-3ylmethyl)-1,3-benzothiazole, -benzoxazole, -benzimidazole, 2-(4-hydroxy-2-methylquinolin-3-ylmethyl)-4H3,1-benzoxazin-4-one, and 4-hydroxy-2-methyl-3-(5-sulfanyl-1H-1,2,4-triazol-3-ylmethyl)quinoline.
查看更多